The activity of metabolic enzymes in the saliva of lung cancer patients

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2017, Vol 7, Issue 6

Abstract

Background: So far, optimization problems for diagnostics and prognostication aids have been still relevant for lung cancer as a leader in the structure of cancers. Aims and Objectives: A search for regularities of changes in the saliva enzyme activity in patients with lung cancer. Materials and Methods: In the case-control study, 859 people divided into two groups took part: Primary (lung cancer, n = 286) and control (conventionally healthy, n = 573). All the participants went through a questionnaire survey, saliva biochemical counts, and a histological verification of their diagnosis. The enzyme activity was measured by spectrophotometry. Between group differences were measured with the nonparametric test. Results: In terms of lung cancer, we observe metabolic changes described with decreased de Ritis coefficient (P ˂ 0.001), as well as the increased activity of alanine aminotransferase (P = 0.022), alkaline phosphatase (P ˂ 0.001), gamma-glutamyl transpeptidase (P = 0.043), and α-amylase (P ˂ 0.001). We have identified specifics of the change in the enzyme activity depending on a histological type and a growth form of the tumor. There is the observable increased activity of α-amylase in the saliva in lung adenocarcinoma and neuroendocrine tumors (P ˂ 0.001). It has been found that irrespective of the histological type of lung cancer in a transition from central to peripheral forms of growth; there is the observable increased activity of all the enzymes. The significantly reduced activity of aspartate aminotransferase (by 51.4% for adenocarcinoma, P = 0.032; 48.8% for squamous cell lung cancer, P = 0.042) is a distinctive feature of central lung cancer. Conclusion: The nature of the change in the enzyme activity is ambiguous and to a greater degree depends on the tumor form of growth (central/peripheral lung cancer) than the histological type (adenocarcinoma/squamous cell lung cancer).

Authors and Affiliations

Lyudmila V Belskaya, Victor K Kosenok

Keywords

Related Articles

Effect of prescription waiting time on patient satisfaction mediated by service quality of pharmacy unit in public hospital in Bandung city

Background: The Indonesia National Health Insurance (NHI) is one of the social protections to ensure all people to health. Improving the quality of good service is a demand for pharmacy unit to improve the services quali...

Prescribing pattern of corticosteroids among the dermatology inpatients in a tertiary care teaching hospital of north India - A retrospective, observational study

Background: Glucocorticoids, are one of the commonly prescribed drugs in a large fraction of patients in the dermatology department. The use of corticosteroids has brought a remarkable change in the field of dermatology...

Evaluation of lung function tests in rheumatoid arthritis patients

Background: Pulmonary manifestation is one of the most common extra-articular features in rheumatoid arthritis (RA) leading to significant morbidity. Lung function testing helps in identifying the type of respiratory def...

Does smoking affect intraocular pressure? A cross-sectional study

Background: Tobacco smoking is linked to ocular conditions such as cataract, age-related macular degeneration, and glaucoma. Glaucoma is the most common cause of irreversible blindness and the second most common cause of...

Analysis of undergraduate pharmacology annual written examination papers at Pt. B. D. Sharma University of Health Sciences Rohtak

Background: Written examinations are the most commonly employed methods for assessing the knowledge and clinical competence of undergraduate medical students. The assessment tools commonly employed in the theory paper ar...

Download PDF file
  • EP ID EP290001
  • DOI 10.5455/njppp.2017.7.0204402032017
  • Views 61
  • Downloads 0

How To Cite

Lyudmila V Belskaya, Victor K Kosenok (2017). The activity of metabolic enzymes in the saliva of lung cancer patients. National Journal of Physiology, Pharmacy and Pharmacology, 7(6), 646-653. https://europub.co.uk/articles/-A-290001